ERIS LIFESCIENCES
Back to Balance Sheet
|
ERIS LIFESCIENCES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹-537 Cr | ₹-158 Cr | ₹-230 Cr | ₹321 Cr | ₹428 Cr |
What is the latest Net Current Assets ratio of ERIS LIFESCIENCES ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹-537 Cr |
| Mar2025 | ₹-158 Cr |
| Mar2024 | ₹-230 Cr |
| Mar2023 | ₹321 Cr |
| Mar2022 | ₹428 Cr |
How is Net Current Assets of ERIS LIFESCIENCES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹-537 Cr | Negative | |
| Mar2025 | ₹-158 Cr | Negative | |
| Mar2024 | ₹-230 Cr | Negative | |
| Mar2023 | ₹321 Cr | -24.83 | |
| Mar2022 | ₹428 Cr | - | |
Compare Net Current Assets of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹17,143.3 Cr | -2.7% | -3.7% | -22.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,478.0 Cr | -0.8% | -2.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,031.0 Cr | 1.9% | 6.6% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,216.0 Cr | 0.3% | 2% | 35.9% | Stock Analytics | |
| CIPLA | ₹112,205.0 Cr | 0.9% | -0.8% | -10.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,040.0 Cr | 0.1% | 1.4% | -9.3% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | -2.7% |
-3.7% |
-22.3% |
| SENSEX | -2.8% |
-6.1% |
-11.9% |
You may also like the below Video Courses